Strategy & Innovation Diagnostics for Scaleups & Growth
Helping HealthTech, MedTech and Wellbeing scaleups diagnose issues and opportunities across business strategy, innovation strategy, product strategy and product innovation to strengthen scalability, accelerate sustainable growth and increase the probability of product success.
Why Scaleups Struggle to Grow
Listen to Why SCALE Diagnostics Exist (2 min) • Narration: Why growth creates complexity, hidden pressures and new risks
As businesses grow, complexity increases across products, operations, teams and customer experience. What once worked well becomes harder to coordinate, creating operational friction, slower decision-making and increasing pressure across the organisation.
Many leadership teams seek help because growth is no longer delivering the results they expected. Performance slows, complexity increases and it becomes harder to understand what is really limiting progress. The visible symptoms are rarely the underlying cause. Each SCALE diagnosis service helps identify the underlying causes limiting growth and the opportunities to accelerate it before deciding what to do next.
In HealthTech, MedTech and Wellbeing organisations, these challenges rarely emerge through one major failure. More often, they develop gradually as products, operations, leadership priorities and customer expectations become harder to keep aligned.
Successful scale-up is rarely limited by opportunity. More often, growth slows because products, markets and organisational capability fail to evolve together. The result is increasing complexity, reduced focus and weaker execution at the point greater capability is needed most.
How we Help
Listen to How SCALE Diagnostics Creates Clarity (2 min) • Narration: How we uncover what is really limiting growth and what needs attention next
Identifying the causes limiting growth & the opportunities to accelerate it.
SCALE Diagnostics helps leadership teams step back and identify where growth may be creating hidden pressure, operational inefficiencies or weakening alignment before these issues begin affecting scalability, profitability or execution more seriously.
The diagnostics are designed to help businesses identify where:
→ products and innovation priorities are drifting
→ customer experience and adoption are weakening
→ operational complexity is increasing
→ leadership and organisational capability are struggling to scale effectively
before these issues become more expensive, disruptive or difficult to reverse later.
The work focuses on helping organisations strengthen the products, systems and capabilities that support sustainable growth, operational performance and long-term competitiveness.
Rather than overwhelming organisations with process or consulting theatre, the emphasis remains practical, commercially grounded and focused on helping businesses scale products, operations and organisational capability more coherently over time.
The SCALE Startegic Services
Listen to the SCALE Diagnostic Services (3 min) • Narration: Nine diagnostics for investigating product, market and organisational growth challenges
PRODUCT: Diagnostics for Product-led Growth
Understanding where products, innovation activities and portfolio decisions may be limiting growth, creating complexity or weakening competitiveness.
MARKET: Diagnostics for Customer Growth
Understanding where customer, market and growth challenges may be affecting adoption, retention or expansion opportunities.
ORGANISATION: Diagnostics for Organsiational Growth
Understanding where operational, manufacturing and organisational challenges may be limiting performance, efficiency or sustainable growth.
Together, these diagnostics help leadership teams understand where complexity, fragmentation or operational strain may be slowing progress, weakening performance or limiting sustainable growth.
SCALE Diagnostics forms part of JASSELL Advisory’s wider Strategy & Innovation Consulting practice supporting HealthTech, MedTech and Wellbeing organisations across product scaling, operational growth and transformation.
Product Portfolio Diagnosis
See your portfolio clearly. Decide with confidence.
Issues
As organisations grow, product portfolios often become more difficult to manage. Existing products compete with new opportunities, priorities become harder to balance and investment decisions become less clear. Over time, resources can become spread across too many initiatives, creating complexity, weakening prioritisation and making it harder to determine where future growth will come from.
Aim
This diagnostic helps leadership teams understand whether the portfolio remains commercially focused, strategically aligned and capable of supporting sustainable growth. It identifies where value is being created, lost or diluted and highlights where capital, resources and management attention may be producing weaker returns than expected or could be deployed more effectively.
Why it matters
Portfolio problems rarely appear all at once. More often, complexity builds gradually through unclear priorities, overlapping investments, legacy products and decisions that no longer reflect changing customer, operational or market realities. Over time, this weakens focus, slows execution and reduces the return generated across the portfolio.
Without a disciplined approach to portfolio prioritisation, organisations risk investing heavily while becoming less aligned, less differentiated and harder to scale effectively.
The risks
Research from MIT Sloan Management Review (2020) and the International Journal of Managerial Studies and Research (2020) shows that organisations often experience strategic drift when product priorities, market realities and investment decisions become misaligned during periods of growth. As complexity increases, unclear prioritisation and fragmented portfolio decisions can weaken performance, slow execution and reduce long-term competitiveness.
These risks rarely emerge through one major failure. More often, they build gradually through accumulated complexity, weak prioritisation and investments that no longer support strategic direction.
How we help
The diagnostic examines portfolio performance, strategic alignment, commercial contribution and operational complexity to identify where value is eroding, resources are misaligned or investment decisions require reassessment.
The work helps leadership teams understand which products are strengthening growth, where complexity is limiting performance and where clearer prioritisation may improve focus, scalability and long-term value creation.
What you recieve
→ review of portfolio structure and product performance
→ assessment of commercial contribution and strategic alignment
→ identification of complexity, overlap and investment gaps
→ evaluation of legacy products and resource allocation
→ portfolio prioritisation and optimisation recommendations
What improves
Organisations leave with clearer portfolio visibility, stronger investment discipline and better-informed decisions around product focus, optimisation and long-term growth.
The result is a more focused and strategically aligned portfolio — with clearer priorities, reduced complexity and stronger confidence in future investment decisions.
Product Performance Diagnosis
See where your product is slowing growth and how to strengthen it.
Issues
As organisations scale, existing products often struggle to keep pace with rising customer expectations, competitive pressure and operational demands. What once worked well can gradually become harder to maintain, more expensive to support or less aligned with how customers behave and use products today.
Aim
This diagnostic helps leadership teams assess whether existing products continue to deliver strong commercial, operational and customer value — or whether hidden friction, complexity and performance drift are beginning to limit growth.
Why it matters
Many organisations focus heavily on launching new products while existing ones quietly accumulate inefficiencies, technical debt and experience gaps. Over time, products that once created strong value can become harder to scale, more costly to support and less effective at meeting changing customer expectations.
As drift increases, organisations often experience rising operational strain, weaker customer satisfaction, declining margins and growing pressure to modernise products that no longer perform as effectively as they once did.
The risks
Research from Harvard Business Review (2013), the Journal of Service Research (2007) and Forrester Research (2021) shows that fragmented product experiences, weak improvement practices and unresolved friction points significantly reduce customer loyalty, perceived value and long-term commercial performance.
These risks rarely emerge suddenly. More often, they build gradually through accumulated complexity, outdated assumptions and products that evolve more slowly than customer expectations, operational demands or competitive pressures.
How we help
The diagnostic examines product usability, reliability, cost to serve, operational fit and commercial contribution to identify where friction, waste or complexity may be limiting performance and scalability.
The work helps leadership teams understand where products are losing value, where improvement efforts may create the greatest impact and what requires attention before larger redesign, reinvestment or modernisation decisions are made.
What you recieve
→ review of product performance, usability and operational fit
→ assessment of cost drivers, friction points and technical debt
→ dentification of outdated assumptions and scalability constraints
→ evaluation of customer, operational and commercial alignment
→ product improvement and prioritisation recommendations
What improves
Organisations leave with clearer visibility of product performance risks, stronger understanding of improvement priorities and better-informed decisions around optimisation, reinvestment and modernisation.
The result is a more focused and commercially effective product experience — with reduced friction, improved scalability and stronger confidence in future product decisions.
AI-Driven Product Innovation Diagnosis
See where AI can strengthen innovation – safely and responsibly.
Issues
AI is reshaping how products are researched, designed, developed and improved. For growing organisations, the challenge is rarely whether AI should be adopted. The challenge is understanding where AI can genuinely strengthen innovation, improve decision-making and create measurable value across the product lifecycle.
As organisations scale, AI initiatives often emerge across different teams, tools and workflows without a clear product strategy. Opportunities become fragmented, investment can be duplicated, governance weakens and AI risks becoming another disconnected technology initiative rather than a capability that strengthens product innovation, commercial performance and long-term competitive advantage.
Aim
This diagnostic helps leadership teams assess where AI is creating value today, where risks or capability gaps exist and how innovation systems can evolve more safely, responsibly and effectively.
Why it matters
AI is rapidly becoming a competitive advantage across product innovation, research and operational decision-making. But without clear direction, organisations often adopt tools faster than they develop the capability, governance or integration needed to use them effectively.
Over time, this creates innovation drift — where AI increases complexity rather than reducing it. Teams duplicate effort, outputs become difficult to validate and disconnected experimentation weakens consistency, quality and strategic focus.
In regulated product environments, poorly governed AI adoption can also introduce operational, regulatory and reputational risks that become increasingly difficult to manage as innovation activity scales.
The risks
Research from Harvard Business Review (2019), Oxford Review of Economic Policy (2018) and Gartner Research (2022) shows that innovation performance weakens when organisations adopt emerging technologies without aligned governance, capability development or integrated decision-making structures.
These risks rarely come from AI itself. More often, they emerge through fragmented adoption, unclear ownership, inconsistent workflows and weak alignment between technology experimentation, operational reality and long-term innovation strategy.
How we help
The diagnostic examines how AI currently supports research, discovery, ideation, development, validation and innovation governance across the organisation.
The work heThe diagnostic examines how AI currently supports research, discovery, ideation, development, validation and innovation governance across the organisation.
What you receive
The work typically includes:
→ review of AI use across research, innovation and development workflows
→ assessment of governance, capability and operational alignment
→ identification of fragmented adoption, workflow gaps and risk areas
→ evaluation of where AI adds value – and where it may not
→ AI innovation and capability development recommendations
What improves
Organisations leave with clearer visibility of how AI supports innovation today, stronger understanding of capability and governance gaps and better-informed decisions around responsible AI adoption and investment.
The result is a more focused and commercially effective innovation system — with stronger governance, reduced experimentation waste and greater confidence in how AI supports long-term product and organisational growth.
Intellectual Property Strategy Diagnosis
See what you own – and what truly needs protecting.
Issues
As organisations scale, intellectual property often becomes fragmented, inconsistently managed or disconnected from broader commercial strategy. Teams may not fully understand what they own, which assets create real competitive value or where vulnerabilities exist across products, partnerships and market expansion activity.
Over time, valuable innovations can remain undocumented, commercially important knowledge may be insufficiently protected, and opportunities to build competitive advantage may be lost.
Aim
This diagnostic helps leadership teams assess whether intellectual property is properly supporting growth, defensibility and long-term value creation.
Why iT matters
Intellectual property is not only a legal issue – it is a strategic growth asset. As organisations scale, product innovation, partnerships, supplier relationships and international expansion all increase exposure to competitive replication, ownership disputes and weakened defensibility.
Without a clear IP strategy, organisations often invest heavily in innovation while failing to protect the very assets creating long-term value. Over time, this weakens differentiation, reduces leverage in partnerships or investment discussions and increases commercial vulnerability as markets become more competitive.
The risks
Research from the Strategic Management Journal (2007), Harvard Business School (2016) and OECD (2021) shows that organisations become increasingly vulnerable when intellectual property, business model evolution and strategic decision-making fail to remain aligned during periods of growth and market change.
These risks rarely emerge through one major event. More often, they build gradually through undocumented knowledge, weak ownership clarity, under-protected innovation and commercial strategies that evolve faster than internal IP governance and protection practices.
How does this service help?
The diagnostic examines intellectual property assets, ownership clarity, competitive exposure and alignment between innovation activity, commercial strategy and long-term growth objectives.
The work helps leadership teams understand where intellectual property is strengthening competitive advantage, where vulnerabilities or missed opportunities exist and what requires attention before making larger decisions around protection, partnerships, licensing or expansion.
How we help
The diagnostic examines intellectual property assets, ownership clarity, competitive exposure and alignment between innovation activity, commercial strategy and long-term growth objectives.
The work helps leadership teams understand where intellectual property is strengthening competitive advantage, where vulnerabilities or missed opportunities exist and what requires attention before making larger decisions around protection, partnerships, licensing or expansion.
What you recieve
→ review of intellectual property assets, ownership and documentation
→ assessment of competitive exposure and defensibility risks
→ identification of unprotected innovation and strategic gaps
→ evaluation of IP alignment with growth and commercial strategy
→ intellectual property and strategic protection recommendations
What improves
Organisations leave with clearer visibility of intellectual property risks, stronger understanding of strategic value and better-informed decisions around protection, investment and long-term commercial positioning.
The result is a more deliberate and commercially aligned IP strategy – with stronger defensibility, improved strategic clarity and greater confidence in future growth and expansion decisions.
Customer Experience Diagnosis
Improve adoption. Strengthen retention.
Issues
As organisations scale, customer experience often becomes harder to manage consistently across products, services and operational systems. Customer needs evolve, expectations increase and different parts of the organisation can begin developing at different speeds, creating inconsistencies across how customers experience, use and value the offering.
Aim
This diagnostic helps leadership teams assess whether the organisation remains aligned with customer needs, expectations and behaviours in practice – before friction, inconsistency or weak adoption begin affecting growth, retention and long-term customer value.
Why it matters
Customer experience is one of the strongest drivers of adoption, retention and sustainable growth. As organisations scale, operational complexity often creates distance between the business and the people it serves. Processes become fragmented, expectations rise and experiences that once felt clear and trusted become harder to deliver consistently.
Over time, friction accumulates across touchpoints, customer trust weakens and the organisation risks losing alignment with how people actually behave, decide and adopt products or services in real-world settings.
The risks
Research from Harvard Business Review (2013), the Journal of Service Research (2007) and Forrester Research (2021) shows that fragmented customer experience, behavioural misalignment and inconsistent service delivery are strong predictors of declining loyalty, weaker adoption and increased churn – particularly in regulated or trust-sensitive sectors.
These risks rarely emerge through one major failure. More often, they build gradually as customer expectations evolve faster than internal systems, teams and operational delivery models.
How we help
The diagnostic examines customer experience, behavioural alignment, adoption pathways and service delivery to identify friction, inconsistency and gaps that may be weakening trust, engagement or commercial performance.
The work helps leadership teams understand where customer experiences are becoming disconnected, where expectations are no longer being met consistently and what requires attention to strengthen alignment, retention and scalable growth.
What you recieve
→ review of customer experience and adoption pathways
→ assessment of engagement, retention and trust factors
→ identification of friction points and behavioural gaps
→ evaluation of service and operational alignment
→ customer experience and adoption improvement recommendations
What improves
Organisations leave with clearer visibility of customer experience risks, stronger understanding of adoption barriers and better-informed decisions around retention, engagement and service improvement.
The result is a more consistent and commercially aligned customer experience – with stronger trust, improved adoption and greater confidence in the systems supporting long-term scalable growth.
International Product Diagnosis
See your international readiness clearly before you expand.
Understanding The Problem
International expansion creates significant opportunity — but it also introduces new commercial, operational and regulatory complexity. Products that perform well in one market do not always translate successfully into another. Customer expectations shift, buying behaviour changes and the demands placed on localisation, compliance and market execution increase quickly as growth accelerates.
Aim
This diagnostic helps leadership teams assess whether the organisation, its products and supporting capabilities are genuinely prepared for international growth – before expansion pressure, fragmented execution or unrealistic assumptions begin weakening momentum and increasing risk.
Why it matters
International growth rarely fails because the product itself is weak. More often, organisations underestimate the complexity of entering and operating within new markets. Expansion decisions made too quickly can stretch teams, weaken focus and expose operational or commercial gaps that were less visible at smaller scale.
As organisations grow internationally, localisation, positioning, regulation and delivery capability all become more strategically important. Without clarity, businesses risk expanding faster than the organisation can realistically support.
The risks
Research from MIT Sloan (2020) and the International Journal of Managerial Studies and Research (2020) shows that organisations frequently struggle during expansion when strategic ambition becomes disconnected from operational capability, market realities and evolving customer expectations.
These risks rarely emerge immediately. More often, they build gradually through misjudged localisation, weak positioning, operational strain, regulatory surprises and internal systems that fail to scale effectively across different markets and environments.
How we help
The diagnostic examines international readiness across market attractiveness, customer behaviour, localisation requirements, operational capability and regulatory considerations to identify where expansion risks, capability gaps or strategic misalignment may exist.
The work helps leadership teams understand which markets offer realistic opportunity, what adaptations may be required and where the organisation may need stronger capability, focus or operational readiness before expanding further.
What you recieve
→ assessment of international market readiness and attractiveness
→ review of localisation, positioning and customer alignment
→ identification of operational, regulatory and scalability risks
→ evaluation of internal capability and expansion readiness
→ international growth and market entry recommendations
What improves
Organisations leave with clearer visibility of expansion risks, stronger understanding of international readiness and better-informed decisions around market entry, localisation and scalable growth planning.
The result is a more deliberate and commercially grounded approach to international growth – with stronger focus, improved readiness and greater confidence in expansion decisions.
Operational Performance Diagnosis
See where operations are straining before they slow your growth.
Issues
As organisations scale, operations often become the hidden constraint behind slowing performance, rising costs and inconsistent delivery. What once worked efficiently at smaller scale can gradually become harder to manage as demand increases, teams expand and operational complexity grows across products, suppliers and internal workflows.
Aim
This diagnostic helps leadership teams assess whether the operational systems, processes and capabilities supporting products and growth remain aligned with the pace and demands of scaling — before operational strain, inconsistency or fragmentation begin limiting performance, scalability and execution.
Why it matters
Operational complexity increases quickly during periods of growth. Processes evolve unevenly, teams begin firefighting and systems that once supported the organisation effectively may no longer scale reliably under greater pressure. Over time, inefficiencies accumulate, decision-making slows and operational inconsistency begins affecting quality, customer confidence and commercial performance.
Without operational clarity, growth becomes increasingly fragile. Organisations often respond reactively to problems rather than building the disciplined operational foundations needed for sustainable scaling.
The risks
Research from the Journal of Operations Management (2004), OECD (2020) and the U.S. Food and Drug Administration (2021) shows that organisations experience rising operational fragility when processes, quality systems and supply chain capability fail to evolve alongside increasing product, regulatory and customer complexity.
These risks rarely emerge through one major operational failure. More often, they build gradually through fragmented workflows, weak process discipline, operational bottlenecks and systems that can no longer reliably support scalable growth.
How we help
The diagnostic examines operational workflows, process performance, capacity, quality management and organisational capability to identify where inefficiency, bottlenecks or operational misalignment may be limiting scalability and execution.
The work helps leadership teams understand where operations are becoming strained, where operational risk is increasing and what requires attention to strengthen efficiency, resilience and long-term delivery capability.
What you recieve
→ review of operational workflows, processes and delivery performance
→ assessment of operational scalability, efficiency and quality systems
→ identification of bottlenecks, inefficiencies and operational risks
→ evaluation of process alignment, capability and operational resilience
→ operational improvement and scalability recommendations
What improves
Organisations leave with clearer visibility of operational constraints, stronger understanding of scalability risks and better-informed decisions around process improvement, operational investment and capability development.
The result is a more resilient and scalable operational foundation — with improved efficiency, reduced operational friction and greater confidence in the systems supporting sustainable growth.
Manufacturing Performance Diagnosis
See where your manufacturing and supply chain are vulnerable – before growth exposes the gaps.
Understanding The Problem
As product-led organisations scale, manufacturing and supply chain decisions become increasingly strategic. The ability to deliver products reliably, efficiently and at the required quality often depends on whether manufacturing capabilities and supply networks can keep pace with growth. What once worked effectively at lower volumes can begin to strain under expansion, international growth and rising regulatory expectations.
Aim
This diagnostic helps leadership teams assess whether manufacturing operations and supply chain systems remain resilient, scalable and aligned with long-term product and growth objectives — before operational vulnerabilities begin limiting performance, reliability or commercial confidence.
Why it matters
Manufacturing and supply chain performance directly influence quality, cost, delivery reliability and customer trust. As organisations scale, operational complexity increases across suppliers, production systems, logistics and quality management processes. What initially appears manageable can gradually become fragile as dependencies deepen and operational strain increases.
Over time, bottlenecks, supplier risk, inconsistent quality and weak operational visibility can begin undermining scalability, slowing growth and increasing exposure to disruption, compliance issues or customer dissatisfaction.
The risks
Research from the Journal of Operations Management (2004), OECD (2020) and the U.S. Food and Drug Administration (2021) shows that manufacturing and supply chain fragility often increases when operational systems, supplier networks and quality processes fail to evolve alongside growing product, market and regulatory complexity.
These risks rarely emerge through one major operational event. More often, they build gradually through supplier concentration, fragmented processes, weak resilience planning and operational systems that become increasingly difficult to scale reliably under pressure.
How we help
The diagnostic examines manufacturing capability, supply chain resilience, supplier dependencies, operational scalability and quality system alignment to identify where vulnerabilities, bottlenecks or operational risks may exist.
The work helps leadership teams understand where operational resilience is weakening, where dependencies or constraints may limit future growth and what requires attention to strengthen reliability, scalability and long-term operational confidence.
What you recieve
→ review of manufacturing capability, workflows and operational performance
→ assessment of supply chain resilience, supplier dependencies and scalability risks
→ identification of bottlenecks, quality risks and operational vulnerabilities
→ evaluation of operational alignment with product, market and regulatory requirements
→ manufacturing and supply chain improvement recommendations
What improves
Organisations leave with clearer visibility of operational vulnerabilities, stronger understanding of resilience risks and better-informed decisions around suppliers, manufacturing capability and operational investment.
The result is a more resilient and scalable operational foundation – with improved reliability, reduced exposure to disruption and greater confidence in the systems supporting long-term growth.
Organisational Performance Diagnosis
See how your organisation leads, decides and collaborates – with clarity.
Understanding The Problem
As organisations scale, leadership capability, decision-making and ways of working often struggle to evolve at the same pace as growth. What once felt aligned, agile and collaborative can gradually become more difficult to coordinate as teams expand, responsibilities become less clear and organisational complexity increases.
Aim
This diagnostic helps leadership teams assess whether organisational structure, leadership capability and ways of working remain aligned with the demands of growth — before misalignment, slower execution or cultural drift begin affecting performance, scalability and the organisation’s ability to deliver consistently.
Why it matters
Leadership and organisational clarity are essential for scalable execution. As organisations grow, complexity increases across teams, priorities and decision-making structures. Without deliberate alignment, organisations often become slower to respond, harder to coordinate and less effective at translating strategy into execution.
Over time, unclear accountability, fragmented collaboration and inconsistent leadership behaviours can begin weakening cohesion, slowing decisions and reducing organisational confidence and performance.
The risks
Research from Harvard Business Review (2019), Academy of Management Journal (2009) and OECD (2019) shows that organisational performance and innovation capability decline when decision pathways become fragmented, leadership alignment weakens and organisational structures fail to evolve alongside increasing complexity.
These risks rarely emerge through one visible breakdown. More often, they build gradually through silo behaviour, unclear ownership, inconsistent leadership practices and organisational systems that no longer support effective communication, accountability or execution at scale.
How we help
The diagnostic examines leadership alignment, organisational design, decision-making structures, collaboration patterns and cultural dynamics to identify where misalignment, bottlenecks or organisational drift may be limiting performance and execution.
The work helps leadership teams understand where organisational friction is developing, where decision-making or accountability may be weakening and what requires attention to strengthen alignment, coordination and scalable execution.
What you recieve
→ review of leadership structures, organisational design and decision pathways
→ assessment of collaboration, accountability and communication effectiveness
→ identification of organisational friction, silo behaviour and execution gaps
→ evaluation of leadership alignment and organisational scalability
→ organisational improvement and capability development recommendations
What improves
Organisations leave with clearer visibility of organisational risks, stronger understanding of leadership and alignment challenges and better-informed decisions around structure, collaboration and ways of working.
The result is a more aligned and scalable organisation – with clearer accountability, stronger execution and greater confidence in the leadership and systems supporting sustainable growth.